Latigo Biotherapeutics, Inc. · NASDAQ:LTGO
AI Biotechnology LLC reported a 5.00% stake in Latigo Biotherapeutics, Inc. (Schedule 13G)
Event Aug 11, 2026 · Filed Aug 18, 2026
AI Biotechnology LLC reported a 5.00% stake in Latigo Biotherapeutics, Inc., 3,185,177 shares, as a passive investor on Aug 11, 2026. Filed Aug 18, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 3,185,177
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AI Biotechnology LLC | 5.00% | 3,185,177 |
| Access Industries Holdings LLC | 5.00% | 3,185,177 |
| Access Industries Management, LLC | 5.00% | 3,185,177 |
| Len Blavatnik | 5.00% | 3,185,177 |
Source
Related
- Latigo Biotherapeutics, Inc.
- AI Biotechnology LLC
- Latigo Biotherapeutics, Inc. shareholders
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 17, 2026
- Schedule 13D · James B. Tananbaum · Aug 17, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 13, 2026
- Form 4 · 5AM Partners VI, LLC · Aug 12, 2026